Mr Wonderful's DeFi Winner
Kevin O'Leary picks one stock from each sector. This is his pick for DeFi.
Read more.
Amit D. Munshi, insider at Arena Pharmaceuticals
Amit D. Munshi Insider Alerts

Get notified the next time Amit D. Munshi buys or sells Arena Pharmaceuticals stock. Enter your email address below to get our daily insider buying and selling report.

Amit D. Munshi Insider Information

Amit D. Munshi has served as a member of Arena Pharmaceuticals’ Board of Directors since June 2016, and as our President and Chief Executive Officer since May 2016. Previously, Mr. Munshi served as President and Chief Executive Officer of Epirus Biopharmaceuticals, Inc. and Percivia LLC, a biotechnology company (sold to JNJ).  Prior to Epirus and Percivia, Mr. Munshi was a co-founder and served as Chief Business Officer of Kythera Biopharmaceuticals, Inc., from 2005 to 2010, (sold $2.1B to AGN) and held multiple leadership positions at Amgen Inc. from 1997 to 2005, including General Manager, Nephrology Europe. Mr. Munshi holds a B.S. in Economics and a B.A. in History from the University of California, Riverside, and an M.B.A. from the Peter F. Drucker School of Management at Claremont Graduate University. Mr. Munshi has 30 years of global biopharmaceutical industry experience in executive management, business development, product development and portfolio management. Mr. Munshi currently serves on the boards of  Pulmatrix, Inc. (Nasdaq: PULM), Enterprise Therapeutics Ltd, and Galecto, Inc.

What is Amit D. Munshi's net worth?

The estimated net worth of Amit D. Munshi is at least $2.40 million as of August 16th, 2021. Mr. Munshi owns 39,550 shares of Arena Pharmaceuticals stock worth more than $2,396,335 as of October 22nd. This net worth evaluation does not reflect any other investments that Mr. Munshi may own. Learn More.

What is Amit D. Munshi's salary?

As the CEO of Arena Pharmaceuticals, Inc., Mr. Munshi earned a total compensation package of $6,896,609.00 in 2020. Mr. Munshi earned a salary of $687,500.00, options awards of $5,676,561.00, non-equity compensation of $514,206.00, and other compensation of $18,342.00.

How do I contact Amit D. Munshi?

The corporate mailing address for Mr. Munshi and other Arena Pharmaceuticals executives is 6154 Nancy Ridge Drive, San Diego CA, 92121. Arena Pharmaceuticals can also be reached via phone at (858) 453-7200 and via email at [email protected]

Has Amit D. Munshi been buying or selling shares of Arena Pharmaceuticals?

Amit D. Munshi has not been actively trading shares of Arena Pharmaceuticals within the last three months. Most recently, on Monday, August 16th, Amit Munshi bought 1,000 shares of Arena Pharmaceuticals stock. The stock was acquired at an average cost of $48.19 per share, with a total value of $48,190.00. Following the completion of the transaction, the chief executive officer now directly owns 39,550 shares of the company's stock, valued at $1,905,914.50.

Who are Arena Pharmaceuticals' active insiders?

Arena Pharmaceuticals' insider roster includes Jayson Dallas (Director), Robert Lisicki (EVP), Robert Lisicki (EVP), and Amit Munshi (CEO).

Are insiders buying or selling shares of Arena Pharmaceuticals?

During the last year, Arena Pharmaceuticals insiders bought shares 4 times. They purchased a total of 3,005 shares worth mmore than $151,841.25. During the last year, insiders at the biopharmaceutical company sold shares 9 times. They sold a total of 161,468 shares worth mmore than $12,426,897.02. The most recent insider tranaction occured on August, 16th when Amit Munshi CEO bought 1,000 shares worth more than $48,190.00. Insiders at Arena Pharmaceuticals own 2.4 % of the company.

Information on this page was last updated on 8/16/2021.

Amit D. Munshi Insider Trading History at Arena Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2021Buy1,000$48.19$48,190.0039,550View SEC Filing Icon  
8/12/2021Buy1,000$50.41$50,410.00View SEC Filing Icon  
8/10/2021Buy1,000$52.91$52,910.00View SEC Filing Icon  
1/19/2021Sell50,000$80.14$4,007,000.0057,750View SEC Filing Icon  
1/15/2021Sell50,000$80.24$4,012,000.0057,750View SEC Filing Icon  
1/12/2021Sell14,877$75.12$1,117,560.2420,627View SEC Filing Icon  
12/8/2020Sell6,517$70.00$456,190.007,750View SEC Filing Icon  
8/31/2020Sell50,000$70.10$3,505,000.0057,750View SEC Filing Icon  
8/28/2020Sell50,000$70.00$3,500,000.0057,750View SEC Filing Icon  
6/2/2020Sell50,000$65.00$3,250,000.0057,750View SEC Filing Icon  
5/22/2020Sell34,800$58.12$2,022,576.0057,750View SEC Filing Icon  
2/13/2020Sell15,200$55.00$836,000.0022,950View SEC Filing Icon  
5/12/2017Buy25,000$1.19$29,750.0076,875View SEC Filing Icon  
4/26/2017Buy50,000$1.41$70,500.001,875View SEC Filing Icon  
See Full Table

Amit D. Munshi Buying and Selling Activity at Arena Pharmaceuticals

This chart shows Amit Munshi's buying and selling at Arena Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arena Pharmaceuticals Company Overview

Arena Pharmaceuticals logo
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.
Read More

Today's Range

Now: $60.59
Low: $60.34
High: $61.42

50 Day Range

MA: $56.84
Low: $45.80
High: $63.74

2 Week Range

Now: $60.59
Low: $45.50
High: $90.19


10,250 shs

Average Volume

477,477 shs

Market Capitalization

$3.70 billion

P/E Ratio


Dividend Yield



Mr Wonderful's DeFi Winner
Kevin O'Leary picks one stock from each sector. This is his pick for DeFi.
Read more.